$0.3059
-0.0034-1.1%
In chiusura: Nov 19, 4:00 PM EST
$0.2960
-0.0099-3.24%
Post-mercato: 5:25 PM EST

The average analyst price target for Tempest Therapeutics is $27, 9021.6% above the current price. Of 4 analysts, 3 rate it Buy and 1 Hold. Targets range from $7 to $65. The latest change came on Sep 24, 2026, when HC Wainwright & Co. lowered its price target on Tempest Therapeutics from $11 to $7 and kept a Buy rating.
Price Target Range — 8 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months